What AI does RayBiotech use?

A recent win we can directly attribute to Apollo was expanding our outbound reach into the regenerative medicine and cell therapy space,an area where we previously had limited visibility. Using Apollo’s segmentation and sequencing tools, we built a targeted list of ~450 qualified contacts across ~120 companies and launched a multi-touch outreach campaign (email + LinkedIn). Within 4–6 weeks, this resulted in: ~38% email open rate ~12% reply rate ~7% meeting booked rate (compared to ~2–3% prior baseline) From this campaign, we secured 8 new discovery calls, which led to 3 active opportunities and 1 signed project (~$25K value) within the first two months. Without Apollo, identifying the right contacts and executing at this scale would have required significantly more manual effort and likely would not have achieved the same conversion rates or speed.